Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction

Abstract Chimeric antigen receptor (CAR) T-cell therapy is a promising and rapidly expanding therapeutic option for a wide range of human malignancies. Despite the ongoing progress of CAR T-cell therapy in hematologic malignancies, the application of this therapeutic strategy in solid tumors has enc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Amirhossein Mardi, Anastasia V. Shirokova, Rebar N. Mohammed, Ali Keshavarz, Angelina Olegovna Zekiy, Lakshmi Thangavelu, Talar Ahmad Merza Mohammad, Faroogh Marofi, Navid Shomali, Amir Zamani, Morteza Akbari
Format: Revisão
Jezik:angleščina
Izdano: 2022
Online dostop:https://doi.org/10.1186/s12935-022-02585-z
https://cancerci.biomedcentral.com/track/pdf/10.1186/s12935-022-02585-z
Oznake: Označite
Brez oznak, prvi označite!

Internet

https://doi.org/10.1186/s12935-022-02585-z
https://cancerci.biomedcentral.com/track/pdf/10.1186/s12935-022-02585-z

Podobne knjige/članki